One of the most potent genetic drivers of prostate cancer is phosphatase and tensin homolog (PTEN), a tumor suppressor gene that is mutated in approximately 20% of primary prostate cancers and in up to 50% of patients with mCRPC (4, 5). The gene discussed is PTEN; the disease is prostate cancer.